Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma
10.1080/02841860600702076
Saved in:
Main Authors: | Chuah, B., Lim, R., Boyer, M., Ong, A.-B., Wong, S.-W., Kong, H.-L., Millward, M., Clarke, S., Goh, B.-C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/131526 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma
by: Toh, H.C., et al.
Published: (2014) -
Systemic treatment for unresectable hepatocellular carcinoma
by: Leowattana W.
Published: (2023) -
A phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma
by: Choo, S. P., et al.
Published: (2013) -
Survival outcomes of metastatic/unresectable hepatocellular carcinoma in patients treated with sorafenib
by: J. Chantharasamee, et al.
Published: (2020) -
Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group
by: Yeo, W., et al.
Published: (2014)